2026

NORM - PBMs - Federal - Comments - Health Extenders - January 2026

Global Benchmark for Efficient Drug Pricing (GLOBE) Model (CMS-5545-P) Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model (CMS-5546-P) - February 2026

NORM - MDPNP - CMS - Comments - IPAY 2028 - May 2026

NORM - MFN - Reconciliation - May 2026

Request for Information on Step Therapy in Proposed Rule for Interoperability Standards and Prior Authorization for Drugs - June 2026

2025

Underwater Biosimilars Coalition - Jan 2025

CY 2026 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P) - Feb 2025

HR 879 Medicare Patient Access and Practice Stabilization Act - March 2025

CSRO Letter to HHS Sec Kennedy on SAD List - April 2025

NORM MedPac Marketing and Networks Letter - April 2025

OMB Deregulation Letter - May 2025

NORM FTC and DOJ RFI on Anticompetitive Regulations- May 2025

NORM Response to CMS RFI on Medicare Regulatory Relief - June 2025

NORM - MFN - Federal - Comments - Senate Reconciliation - ALL LETTERS - June 2025

Medicare and Medicaid Programs; CY 2026 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program - September 2025

CY 2026 Hospital Outpatient Prospective Payment System – Site Neutral Payment for Drug Administration Services - Sep 2025